Gemcitabin Hikma

Gemcitabine is a chemotherapy drug used to treat various cancers. This intravenous medication is manufactured by Hikma Farmacêutica (Portugal), S.A. and is available in the EU.

Gemcitabine is primarily used in the treatment of various types of cancer. It works by interfering with the growth and spread of cancer cells in the body. This medication is often prescribed for conditions like pancreatic cancer, lung cancer, and breast cancer. Patients should consult their healthcare provider to understand what is gemcitabine used for in their specific case.

Common effects of gemcitabine may include nausea, vomiting, fatigue, and a decreased blood cell count. Some patients might experience hair loss or changes in their skin. These effects can vary from person to person and may not affect everyone who takes the medication.

Gemcitabine should be handled with care, as it is a potent chemotherapy drug. It is important to follow the instructions provided by your healthcare provider. Pregnant women or those planning to become pregnant should discuss the risks with their doctor. Always store and administer this medication as directed.

Gemcitabine may interact with other medications, including certain antibiotics and vaccines. It is important to inform your healthcare provider about all the medications you are taking. Avoid alcohol while using gemcitabine, as it may increase the risk of side effects. Always consult your healthcare provider before starting any new medication.